{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_4", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "formation. \n \nHighlights of the PLLR include: \n \n1. The pregnancy letter categories – A, B, C, D and X will be replaced by a narrative risk summary \nbased on available data.  Although the letter category system has been in place since 1979, FDA \nlearned from experience and stakehol der feedback that these letter categories are often \nmisinterpreted as a ‘grading system.’ The pregnancy letter designations were classified based on \nwhat was known from human and animal data. These letter categories"}